How personalised oncology is changing cancer treatment

Dr Philip George Kuttikat explains that personalised oncology uses tumour type, stage, biomarkers, genetic changes, previous treatment and overall health to guide cancer therapy. Studies such as NCI-MATCH and KEYNOTE-158 show how molecular features can help match patients with targeted drugs or immunotherapy, while treatment may be adjusted based on the patient’s response.